Arkolith/Insider Trading/TGTX/Form 4

Lonial Sagar

DirectorTG THERAPEUTICS, INC. (TGTX) · full profile →Form 4 · filed Jun 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$433K
Net Open-Market Flow
-$433K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2024Sell(S)16K$16.87$276K105K
Jun 19, 2024Grant(A)22K—$0122K
Jun 17, 2024Sell(S)10K$16.39$157K99K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-020851) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for TG THERAPEUTICS, INC.

Build

Ask your agent about TGTX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001437749-24-020851"
Ask your agent
Use Arkolith to summarize insider buying and selling at TG THERAPEUTICS, INC.
over the last 90 days and cite the filings.